Parameter | Sex | Reference range | Group | Ingestion period | Follow-up period | |||
---|---|---|---|---|---|---|---|---|
0 w | 4 w | 8 w | 12 w | 16 w | ||||
UA (mg/dL) | M | 3.6-7.0 | A | 6.37 (0.15) | 6.38 (0.17) | 6.39 (0.14) | 6.43 (0.16) | 6.35 (0.16) |
P | 6.36 (0.17) | 6.40 (0.18) | 6.58 (0.17) | 6.41 (0.18) | 6.29 (0.14) | |||
F | 2.7-7.0 | A | 5.09 (0.13) | 4.96 (0.14) | 5.07 (0.12) | 4.98 (0.15) | 5.05 (0.13) | |
P | 5.18 (0.14) | 5.09 (0.14) | 5.18 (0.14) | 5.13 (0.14) | 5.13 (0.14) | |||
BUN (mg/dL) | 8.0-20.0 | A | 13.65 (0.37) | 13.58 (0.37) | 13.12 (0.38) | 12.67 (0.33)** | 13.23 (0.30) | |
P | 13.72 (0.35) | 13.28 (0.35) | 13.31 (0.38) | 12.80 (0.30)** | 13.32 (0.30) | |||
Cre (mg/dL) | M | 0.65-1.09 | A | 0.816 (0.015) | 0.811 (0.014) | 0.809 (0.014) | 0.791 (0.014)** | 0.804 (0.013) |
P | 0.833 (0.019) | 0.828 (0.019) | 0.839 (0.020) | 0.820 (0.019) | 0.826 (0.021) | |||
F | 0.46-0.82 | A | 0.619 (0.014) | 0.610 (0.015) | 0.618 (0.015) | 0.597 (0.013)* | 0.619 (0.015) | |
P | 0.629 (0.014) | 0.617 (0.013) | 0.625 (0.013) | 0.606 (0.012)* | 0.617 (0.012) | |||
Na (mEq/L) | 135-145 | A | 140.5 (0.2)## | 140.6 (0.2) | 140.5 (0.2)# | 140.8 (0.2) | 140.6 (0.2) | |
P | 141.3 (0.2) | 141.0 (0.2) | 141.1 (0.2) | 140.9 (0.2) | 141.0 (0.2) | |||
Cl (mEq/L) | 98-108 | A | 103.9 (0.2) | 103.8 (0.2) | 104.0 (0.2) | 103.8 (0.2) | 103.6 (0.2) | |
P | 104.1 (0.2) | 104.1 (0.2) | 104.2 (0.2) | 103.9 (0.2) | 103.8 (0.2) | |||
K (mEq/L) | 3.5-5.0 | A | 4.18 (0.03)# | 4.08 (0.02)** | 4.16 (0.03) | 4.14 (0.03) | 4.18 (0.03) | |
P | 4.11 (0.03) | 4.05 (0.03) | 4.10 (0.03) | 4.11 (0.02) | 4.16 (0.02)* | |||
Ca (mg/dL) | 8.6-10.2 | A | 9.38 (0.03) | 9.37 (0.04) | 9.34 (0.04) | 9.36 (0.03) | 9.39 (0.03) | |
P | 9.41 (0.04) | 9.34 (0.04)* | 9.40 (0.04) | 9.41 (0.04) | 9.41 (0.03) | |||
Mg (mg/dL) | 1.7-2.6 | A | 2.21 (0.02) | 2.21 (0.01) | 2.18 (0.01)* | 2.19 (0.01) | 2.19 (0.01) | |
P | 2.20 (0.02) | 2.22 (0.02) | 2.21 (0.02) | 2.20 (0.02) | 2.20 (0.02) |